What are the major opportunities in the Inactivated Vaccines market? What are the strategies for the Inactivated Vaccines market?

For detailed insights on the major opportunities and strategies in the Inactivated Vaccines market, Read More

How does the Inactivated Vaccines market relate to the overall economy and other similar markets?

For detailed insights on Inactivated Vaccines's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Inactivated Vaccines market growth? SWOT analysis of the Inactivated Vaccines market.

For detailed insights on the key dynamics influencing the Inactivated Vaccines market growth and SWOT analysis of the Inactivated Vaccines industry, Read More

Inactivated Vaccines Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Inactivated Vaccines Market Report 2026

Name: Inactivated Vaccines Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Inactivated Vaccines Market Overview

• Inactivated Vaccines market size has reached to $6.37 billion in 2025

• Expected to grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%

• Growth Driver: Rising Prevalence Of Infectious Diseases Boost Inactivated Vaccines Market In Combating Diseases

• Market Trend: Innovative Advancements In Inactivated Vaccines By Leading Companies For Disease Prevention

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Inactivated Vaccines Market?

Inactivated vaccines, also known as killed vaccines, are a type of vaccine that contains viruses or bacteria that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are designed to stimulate an immune response without causing disease in the vaccinated individual.

The main types of inactivated vaccines are viral and bacterial vaccines. A viral vaccine is a biological preparation containing weakened or inactivated virus components to stimulate the immune system and provide immunity against the targeted viral infection. These are inactivated by solvent detergent, radiation, pH concentration, heat inactivation and others and are distributed by hospital pharmacies, retail pharmacies and others.

Inactivated Vaccines Market Global Report 2026 Market Report bar graph

What Is The Inactivated Vaccines Market Size and Share 2026?

The inactivated vaccines market size has grown steadily in recent years. It will grow from $6.37 billion in 2025 to $6.61 billion in 2026 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to rising incidence of infectious diseases, advancements in virology research, government funding for immunization, expansion of healthcare infrastructure, public awareness campaigns for vaccination.

What Is The Inactivated Vaccines Market Growth Forecast?

The inactivated vaccines market size is expected to see strong growth in the next few years. It will grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing geriatric population, growth in emerging markets healthcare access, technological advancements in vaccine delivery systems, rise in global immunization initiatives, adoption of multi-dose and combination vaccines. Major trends in the forecast period include advancements in vaccine formulation, expansion of cold chain logistics, increasing demand for pediatric vaccines, growth in government immunization programs, development of combination vaccines.

Book your 30 minutes free consultation with our research experts

Global Inactivated Vaccines Market Segmentation

1) By Type: Viral Vaccine, Bacterial Vaccine

2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine

2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

What Is The Driver Of The Inactivated Vaccines Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the inactivated vaccine market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread from person to person, resulting in a wide range of symptoms and health complications. Tuberculosis is one type of infectious disease. Inactivated vaccines use non-living pathogens to stimulate an immune response, effectively preventing diseases such as polio, hepatitis A and influenza. For instance, in November 2023, according to an article published by Centers for Disease Control and Prevention, a US-based national public health agency, the number of tuberculosis patients in the USA has increased from 8,320 in 2022 to 9,615 in 2023 indicating an increase of 1,295 cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the inactivated vaccine industry.

Key Players In The Global Inactivated Vaccines Market

Major companies operating in the inactivated vaccines market are Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd.

Global Inactivated Vaccines Market Trends and Insights

Major companies operating in the inactivated vaccines market are focusing on expanding product launches and securing regulatory approvals to strengthen their global vaccine portfolios and meet rising immunization needs. For instance, in April 2024, Sanofi S.A., a France-based healthcare company, introduced Verorab, its inactivated rabies vaccine, in the UK for use across all age groups in both pre-exposure and post-exposure situations. This launch highlights the company’s ongoing efforts to expand its range of inactivated vaccines and strengthen its global immunization offerings. The move also reflects increasing investments and rising regulatory momentum surrounding inactivated vaccine development and approvals. As more companies advance similar products and broaden their portfolios, these strategic initiatives are collectively driving significant growth in the inactivated vaccines market, supporting wider protection against infectious diseases.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Inactivated Vaccines Market?

In October 2024, Mankind Pharma Limited, an India-based pharmaceutical company, acquired Bharat Serums & Vaccines Limited (BSV) for an undisclosed amount. With this acquisition, Mankind Pharma aimed to expand into high entry barrier biologics and vaccine manufacturing including capabilities in traditional inactivated vaccines thereby diversifying and upgrading its product portfolio. Bharat Serums & Vaccines is an India-based biopharmaceutical company that develops, manufactures, and markets recombinant biologics, complex injectables, and vaccines, including those using inactivated virus technology.

Regional Insights

North America was the largest region in the inactivated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inactivated Vaccines Market?

The inactivated vaccines market consists of sales of whole-cell inactivated vaccines, subunit or protein subunit vaccines, conjugate vaccines and toxoid vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Inactivated Vaccines Market Report 2026?

The inactivated vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the inactivated vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Inactivated Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.61 billion
Revenue Forecast In 2035	$8.07 billion
Growth Rate	CAGR of 3.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Method Of Inactivation, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Bio
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Inactivated Vaccines Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Inactivated Vaccines Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Inactivated Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Inactivated Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Advancements In Vaccine Formulation

4.2.2 Expansion Of Cold Chain Logistics

4.2.3 Increasing Demand For Pediatric Vaccines

4.2.4 Growth In Government Immunization Programs

4.2.5 Development Of Combination Vaccines

5. Inactivated Vaccines Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Government Immunization Programs

5.4 Research Laboratories

5.5 Retail Pharmacies

6. Inactivated Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Inactivated Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Inactivated Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Inactivated Vaccines Market Size, Comparisons And Growth Rate Analysis

7.3. Global Inactivated Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Inactivated Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Inactivated Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Inactivated Vaccines Market Segmentation

9.1. Global Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vaccine, Bacterial Vaccine

9.2. Global Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

9.3. Global Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

9.4. Global Inactivated Vaccines Market, Sub-Segmentation Of Viral Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine

9.5. Global Inactivated Vaccines Market, Sub-Segmentation Of Bacterial Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

10. Inactivated Vaccines Market Regional And Country Analysis

10.1. Global Inactivated Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Inactivated Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Inactivated Vaccines Market

11.1. Asia-Pacific Inactivated Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Inactivated Vaccines Market

12.1. China Inactivated Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Inactivated Vaccines Market

13.1. India Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Inactivated Vaccines Market

14.1. Japan Inactivated Vaccines Market Overview

14.2. Japan Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Inactivated Vaccines Market

15.1. Australia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Inactivated Vaccines Market

16.1. Indonesia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Inactivated Vaccines Market

17.1. South Korea Inactivated Vaccines Market Overview

17.2. South Korea Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Inactivated Vaccines Market

18.1. Taiwan Inactivated Vaccines Market Overview

18.2. Taiwan Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Inactivated Vaccines Market

19.1. South East Asia Inactivated Vaccines Market Overview

19.2. South East Asia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Inactivated Vaccines Market

20.1. Western Europe Inactivated Vaccines Market Overview

20.2. Western Europe Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Inactivated Vaccines Market

21.1. UK Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Inactivated Vaccines Market

22.1. Germany Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Inactivated Vaccines Market

23.1. France Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Inactivated Vaccines Market

24.1. Italy Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Inactivated Vaccines Market

25.1. Spain Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Inactivated Vaccines Market

26.1. Eastern Europe Inactivated Vaccines Market Overview

26.2. Eastern Europe Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Inactivated Vaccines Market

27.1. Russia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Inactivated Vaccines Market

28.1. North America Inactivated Vaccines Market Overview

28.2. North America Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Inactivated Vaccines Market

29.1. USA Inactivated Vaccines Market Overview

29.2. USA Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Inactivated Vaccines Market

30.1. Canada Inactivated Vaccines Market Overview

30.2. Canada Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Inactivated Vaccines Market

31.1. South America Inactivated Vaccines Market Overview

31.2. South America Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Inactivated Vaccines Market

32.1. Brazil Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Inactivated Vaccines Market

33.1. Middle East Inactivated Vaccines Market Overview

33.2. Middle East Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Inactivated Vaccines Market

34.1. Africa Inactivated Vaccines Market Overview

34.2. Africa Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Inactivated Vaccines Market Regulatory and Investment Landscape

36. Inactivated Vaccines Market Competitive Landscape And Company Profiles

36.1. Inactivated Vaccines Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Inactivated Vaccines Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Inactivated Vaccines Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sinopharm Group Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

37. Inactivated Vaccines Market Other Major And Innovative Companies

Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA

38. Global Inactivated Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Inactivated Vaccines Market

40. Inactivated Vaccines Market High Potential Countries, Segments and Strategies

40.1 Inactivated Vaccines Market In 2030 - Countries Offering Most New Opportunities

40.2 Inactivated Vaccines Market In 2030 - Segments Offering Most New Opportunities

40.3 Inactivated Vaccines Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Inactivated Vaccines Market, Overview Of Key Products - Product Examples

Table 2: Global Inactivated Vaccines Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Inactivated Vaccines Market, Supply Chain Analysis

Table 4: Global Inactivated Vaccines Market, Major Raw Material Providers

Table 5: Global Inactivated Vaccines Market, Major Resource Providers

Table 6: Global Inactivated Vaccines Market, Major Manufacturers (Suppliers)

Table 7: Global Inactivated Vaccines Market, Major Distributors And Channel Partners

Table 8: Global Inactivated Vaccines Market, Key Technologies & Future Trends

Table 9: Global Inactivated Vaccines Market, Major Trends

Table 10: Global Inactivated Vaccines Market, Major End Users

Table 11: Global Inactivated Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Inactivated Vaccines Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Inactivated Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Inactivated Vaccines Market - TAM, US$ Billion, 2025

Table 15: Global Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Inactivated Vaccines Market, Sub-Segmentation Of Viral Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Inactivated Vaccines Market, Sub-Segmentation Of Bacterial Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Inactivated Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Inactivated Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Inactivated Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Inactivated Vaccines Market - Company Scoring Matrix

Table 96: Pfizer Inc. Financial Performance

Table 97: Sinopharm Group Co. Ltd. Financial Performance

Table 98: Merck & Co. Inc. Financial Performance

Table 99: Sanofi S.A. Financial Performance

Table 100: GlaxoSmithKline plc Financial Performance

Table 101: Global Inactivated Vaccines Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Inactivated Vaccines Market, Competitive Dashboard

Table 103: Global Inactivated Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Inactivated Vaccines Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 105: Global, Inactivated Vaccines Market Size Gain ($ Billion), Segmentation By Method Of Inactivation, 2025 – 2030

Table 106: Global, Inactivated Vaccines Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Inactivated Vaccines Market, Overview Of Key Products - Product Examples

Figure 2: Global Inactivated Vaccines Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Inactivated Vaccines Market, Supply Chain Analysis

Figure 4: Global Inactivated Vaccines Market, Major Raw Material Providers

Figure 5: Global Inactivated Vaccines Market, Major Resource Providers

Figure 6: Global Inactivated Vaccines Market, Major Manufacturers (Suppliers)

Figure 7: Global Inactivated Vaccines Market, Major Distributors And Channel Partners

Figure 8: Global Inactivated Vaccines Market, Key Technologies & Future Trends

Figure 9: Global Inactivated Vaccines Market, Major Trends

Figure 10: Global Inactivated Vaccines Market, Major End Users

Figure 11: Global Inactivated Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Inactivated Vaccines Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Inactivated Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Inactivated Vaccines Market - TAM, US$ Billion, 2025

Figure 15: Global Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Inactivated Vaccines Market, Sub-Segmentation Of Viral Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Inactivated Vaccines Market, Sub-Segmentation Of Bacterial Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Inactivated Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Inactivated Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Inactivated Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Inactivated Vaccines Market - Company Scoring Matrix

Figure 96: Pfizer Inc. Financial Performance

Figure 97: Sinopharm Group Co. Ltd. Financial Performance

Figure 98: Merck & Co. Inc. Financial Performance

Figure 99: Sanofi S.A. Financial Performance

Figure 100: GlaxoSmithKline plc Financial Performance

Figure 101: Global Inactivated Vaccines Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Inactivated Vaccines Market, Competitive Dashboard

Figure 103: Global Inactivated Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Inactivated Vaccines Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 105: Global, Inactivated Vaccines Market Size Gain ($ Billion), Segmentation By Method Of Inactivation, 2025 – 2030

Figure 106: Global, Inactivated Vaccines Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Swine Vaccines Market Report 2026 - Global Outlook – By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines), By Disease (Viral Infections...

Ruminant Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated Vaccines, Attenuated Or Modified Live Vaccines, Other Vaccine Types), By Indication (Bovine Respiratory Diseases (BRD), Diarrhea Or Sco...

Conjugate Vaccine Market Report 2026 - Global Outlook – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meni...

Veterinary Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types), By Animal Type (Canine, Feline, Equine, Bovine...

Vaccine Adjuvants Market Report 2026 - Global Outlook – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine...

Inactivated Vaccines Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inacti...

Frequently Asked Questions

How big is the Inactivated Vaccines Market?

The Inactivated Vaccines market was valued at $6.37 billion in 2025, increased to $6.61 billion in 2026, and is projected to reach $8.07 billion by 2030.

What is the Inactivated Vaccines market growth?

The global Inactivated Vaccines market is expected to grow at a CAGR of 5.1% from 2026 to 2035 to reach $8.07 billion by 2035.

Who are the key players in Inactivated Vaccines market?

Some Key Players in the Inactivated Vaccines market Include, Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd. .

What is the anticipated growth trend for the Inactivated Vaccines market?

Major trend in this market includes: Innovative Advancements In Inactivated Vaccines By Leading Companies For Disease Prevention. For further insights on this market. request a sample here

Which region has the most growth potential in the Inactivated Vaccines market?

North America was the largest region in the inactivated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.